United States Court of Appeals
                            For the Eighth Circuit
                        ___________________________

                                No. 17-2204
                        ___________________________

                   In re: Mirapex Products Liability Litigation

                             ------------------------------

                                    Marc Mancini

                        lllllllllllllllllllllPlaintiff - Appellant

                                           v.

                Boehringer Ingelheim Pharmaceuticals, Inc., et al.

                      lllllllllllllllllllllDefendants - Appellees
                                       ____________

                    Appeal from United States District Court
                   for the District of Minnesota - Minneapolis
                                   ____________

                           Submitted: October 16, 2018
                             Filed: January 10, 2019
                                 ____________

Before SMITH, Chief Judge, LOKEN and GRUENDER, Circuit Judges.
                              ____________

LOKEN, Circuit Judge.

      Mirapex is a dopamine agonist that is FDA-approved for treating adults with
Parkinson’s disease and movement disorders. On December 30, 2010, Marc Mancini
filed this action against the defendant pharmaceutical companies, alleging they are
liable for substantial gambling and other financial losses that resulted from obsessive
compulsive behavior, a side effect of taking Mirapex. The action was filed in the
District of Minnesota as part of the multi-district Mirapex Products Liability
Litigation. Mancini appeals the district court’s1 grant of summary judgment
dismissing all claims as barred by the applicable California statute of limitations. He
argues the district court erred in not tolling the statute of limitations because he was
“insane” and in rejecting his “continuing violations” theory, issues we review de
novo, and abused its discretion in denying his motion to stay defendants’ motion for
summary judgment pending discovery. We affirm.

                                   I. Background.

       Mancini is a resident of California and a successful educator and travel
industry speaker and consultant. In June 2004, doctors noted symptoms consistent
with mild idiopathic Parkinson’s disease. In January 2006, Dr. Mark Lew, Mancini’s
treating neurologist, prescribed Mirapex to treat worsening symptoms.

       On January 3, 2008, Mancini reported to Dr. Lew that he experienced increased
gambling and other compulsive behaviors after taking Mirapex. Dr. Lew’s notes
stated that Mancini reported “gambling and winning but not excessively.” Dr. Lew
informed Mancini of a possible association between Mirapex and compulsive
behaviors such as gambling. On April 23, 2008, Mancini again reported gambling
and other compulsive behaviors. Dr. Lew’s notes from this visit stated that Mancini
“has increasing stress at work” and “has become a bit more compulsive.” “He tells
me that this is controlled, and he does not have any significant problems,” Dr. Lew


      1
       The Honorable Michael J. Davis, United States District Judge for the District
of Minnesota, adopting the report and recommendations of the Honorable Franklin
L. Noel, United States Magistrate Judge for the District of Minnesota.

                                          -2-
wrote, “but with the stress, he has noted the compulsions to be a bit more intense.
On occasion he . . . described it as ‘driving a car without brakes.’” Dr. Lew told
Mancini he had “substantial and significant concerns” about Mancini’s gambling and
impulsive behavior. “We talked about the potential of simply cutting back on his
Mirapex . . . . Currently he is quite resistant to this. He will return to see me in 3
months’ time.”

       Mancini continued to take Mirapex until mid-July 2010, when his family
learned of substantial debts resulting from gambling. Three days after stopping
Mirapex, Mancini saw Dr. Lew, who noted worsening tremors but advised that
Mancini “needs to stay off his Mirapex” and turn to other “therapeutic options.” Dr.
Lew’s notes stated that “every visit I have had since [Mancini] has been on Mirapex
for better than 5 years, we discuss[ed] the potential for compulsive behaviors, and he
flat out denied any significant problem.”

                                   II. Discussion.

       In reviewing whether Mancini’s claims are time-barred, important issues are
not disputed. The parties agree that California law governs the statute of limitations
issue, and that California’s two year statute of limitations for personal injury claims
resulting from the ingestion of pharmaceutical drugs applies. See Cal. Code Civ. P.
§§ 335.1, 340.8(a). The district court found, and Mancini does not dispute on appeal,
that his claims initially accrued no later than April 23, 2008, because he suspected or
should have suspected that he had been wronged by defendants as a result of his visits
to Dr. Lew in January and April 2008. Thus, the claims filed in December 2010
appear to be time-barred. But Mancini argues the district court erred in granting
summary judgment because the statute of limitations was tolled until July 2010, and
because continuing violations are not time-barrred.




                                         -3-
       A. The Tolling Issue. As relevant here, section 352(a) of the California Code
of Civil Procedure provides that, “[i]f a person entitled to bring an action . . . is, at the
time the cause of action accrued . . . insane, the time of the disability is not part of the
time limited for the commencement of the action.”2 Consistent with the statute’s
plain language, it applies even if the plaintiff’s insanity is caused by the wrongful act
of the defendant. See Feeley v. S. Pac. Transp. Co., 

, 667 (Cal.
App. 1991). Thus, if Mancini was “insane” within the meaning of § 352(a) when his
claim accrued in early 2008, the two-year statute of limitations would be tolled,
presumably until he stopped taking Mirapex in July 2010. Mancini argues the district
court erred in granting defendants summary judgment on this issue.

       The statute, first enacted in 1872, does not define the word “insane.” In an
early case, the Supreme Court of California affirmed a jury verdict that the plaintiff
was insane when the cause of action accrued:

       It is true that the complaint and findings . . . do not use the words
       “unsound” or “insane,” but the finding that he was incapable of caring
       for his property or transacting business or understanding the nature or
       effects of his acts was equivalent to a finding in express terms that the
       deceased was insane within the meaning of the statute of limitations.

Pearl v. Pearl, 

, 846 (Cal. 1918). Many years later, in the leading case of
Hsu v. Mt. Zion Hospital, 

, 664-67 (Cal. App. 1968), the California
Court of Appeal affirmed a jury verdict that plaintiff’s claims were time-barred
because she was not “insane” when the claims accrued, even though she was


       2
          In 2014, the California Legislature amended § 352(a) to replace the term
“insane” with the phrase “lacking the legal capacity to make decisions.” 2014 Cal.
Stat. ch. 144, § 4. Courts continue to rely on pre-2014 case law in interpreting the
amended statute. See, e.g., Lang v. Sacramento Sheriff Dep’t, No. 2:14-cv-0777,

, at *2 (E.D. Cal. Mar. 23, 2017).

                                            -4-
committed to a state hospital for the mentally disturbed shortly after the incident. The
jury was instructed that, “to find that plaintiff was insane, you must find that she was
incapable of caring for her property, or transacting business or understanding the
nature or effects of her acts.” 

The Court of Appeal ruled that this
instruction “is taken directly from Pearl v. Pearl . . . and is a definition of insanity
recognized by [other Court of Appeal] decisions.” 

further explained:

      The cases cited above, such as Pearl . . . do not purport to hold that this
      language is the sole definition of insanity or that the three conditions
      there set forth are the exclusive tests of mental incompetence for
      purposes of tolling the statute of limitations. As we understand these
      cases, the basic question to be resolved by the jury is whether the
      allegedly insane plaintiff is sufficiently aware of the nature or effects of
      his acts to be able to comprehend such business transactions as the
      hiring of an attorney and the instigation of a legal action.

The Court concluded that the claim was time-barred because
the jury reasonably found that the statute of limitations began to run when plaintiff
“was released from the hospital, managed a sixteen-unit apartment building, and took
care of her two minor children during March through May 1959.” 

case, undisputed evidence established that, when his cause of action
accrued in early 2008, Mancini was a full-time college professor, serving as the chair
of his department. He earned $57,800 from speaking engagements in 2008, $7,600
before April. He owned and operated two rental properties. He had never been
diagnosed with or treated for mental illness or psychological disorder. Mancini
reported his gambling and other compulsive behaviors to Dr. Lew in January and
April 2008. Dr. Lew advised that this behavior may be a side effect of taking
Mirapex and suggested Mancini consider “cutting back,” a suggestion he “resisted”
for more than two years. At no point did Dr. Lew question Mancini’s competence to



                                          -5-
care for himself or manage his affairs, nor is there evidence that anyone questioned
his legal competence.

      Mancini relies on two documents to support his claim of insanity. First, when
Mancini visited Dr. Lew two weeks after he stopped taking Mirapex and over two
years after his cause of action accrued. Dr. Lew’s visit notes reported:

      [Mancini] is dramatically insightful into the problems that have evolved
      over the last several years. He feels that he was somewhat disconnected
      from the potential effects of his actions while he was taking Mirapex.
      At that time . . . he covered his activities and did not confide in his
      significant other, and basically lied to me each time I asked him about
      how he was doing. This was all related to his lack of insight caused by
      behavioral changes from his Mirapex . . . . He appears today to be
      dramatically improved with regard to his insight and understanding of
      his compulsions and behavioral change. He appears to be much more
      firmly based in reality today.

Second, Mancini submitted a December 2012 affidavit averring that, while taking
Mirapex, he was “not firmly based in reality, lacked insight into [his] actions, was
disconnected from reality, was incapable of transacting business in a competent
manner and generally could not understand or appreciate the nature, effects or
consequences of [his] acts.” The affidavit listed ways his gambling and “unreliable
behavior” had injured client relations, hastened his retirement as a college professor,
“tarnished my reputation as a speaker,” and caused him to make a poor investment in
June 2007 without his customary “exhaustive research and due diligence.”

       The district court concluded that the July 2010 opinion of Dr. Lew, who was
a treating neurologist, not a psychiatrist, and the assertions in Mancini’s affidavit
failed to meet his burden of showing that he was insane at the time his cause of action
accrued. “The court concludes that no reasonable jury could find that Mancini was
incapable of caring for his property, transacting business, or understanding the nature

                                         -6-
or effects of his acts in January or April 2008.” After careful review of the summary
judgment record, we agree. Mancini must provide more than a scintilla of evidence
to carry his burden. Nuacke v. City of Park Hills, 

, 927 (8th Cir. 2002).
The undisputed evidence of his business and financial success well into 2008, his
contemporaneous recognition of increasingly compulsive behaviors, and his
understanding from Dr. Lew that taking Mirapex may be their cause, establish that
he was not insane when the cause of action accrued because he was “sufficiently
aware of the nature or effects of his acts to be able to comprehend such business
transactions as the hiring of an attorney and the instigation of a legal action.” 

; see also Gazal v. Boehringer Ingelheim Pharm., Inc., 

, 840 (8th Cir. 2011) (concluding that a similar tolling provision in the Texas
Civil Practice and Remedies Code did not apply because plaintiff managed a
profitable company and sought treatment for the side effects of Mirapex, and no one
questioned his competence to care for himself); Sommer v. UNUM Life Ins. Co. of
Am., 

(table), 

at *1 (9th Cir. Mar. 24, 1999)
(plaintiff’s “own actions, continued employment, and substantial income indicate that
he was not ‘insane’”).

       B. The Continuing Violations Issue. Mancini next argues that each ingestion
of Mirapex gives rise to a separate and distinct claim. Therefore, even if the statute
of limitations initially accrued in early 2008 and was not tolled by insanity, damages
for injuries suffered due to dosages of Mirapex taken within two years of December
30, 2010, are not barred by the statute of limitations. In effect, he argues that taking
each dose of Mirapex gave rise to nearly 5,000 distinct and separate claims against
defendants from January 2006 to July 2010. We agree with the district court that this
counter-intuitive argument is without merit.

      “The longstanding rule in California is that a single tort can be the foundation
for but one claim for damages.” Grisham v. Phillip Morris U.S.A., Inc., 

, 1161 (Cal. 2007) (cleaned up). However, the Supreme Court of California, like

                                          -7-
other jurisdictions, has adopted what it calls a “continuing accrual” principle that it
applies to breaches of continuing or recurring obligations:

      When an obligation or liability arises on a recurring basis, a cause of
      action accrues each time a wrongful act occurs, triggering a new
      limitations period. Because each new breach of such an obligation
      provides all the elements of a claim -- wrongdoing, harm, and causation
      -- each may be treated as an independently actionable wrong with its
      own time limit for recovery.

Aryeh v. Canon Bus. Sols., Inc., 

, 880 (Cal. 2013) (citations omitted).
We have applied the same principle under federal law, calling it a “continuing
violations” doctrine and noting that “[t]he critical question is whether a present
violation exists.” Ashley v. Boyle’s Famous Corned Beef Co., 

, 168 (8th
Cir. 1995) (en banc) (emphasis in original), quoting United Air Lines, Inc. v. Evans,

, 558 (1977).

       Though Mancini invoked this principle in arguing to the district court and on
appeal, he failed to identify what present, ongoing violation existed after his cause
of action accrued. His claims are based on the theory that defendants’ failure to
adequately warn him of the behavioral side effects of taking Mirapex led to
compulsive gambling and financial ruin. Mirapex was FDA-approved for treating
Parkinson’s disease, and was prescribed by Mancini’s treating neurologist for this
purpose. Thus, as the district court observed when the summary judgment motion
was argued, “here, the wrongdoing isn’t taking the pill.”

       In these circumstances, it is logical to conclude there was a single wrongdoing
that ended -- accrued -- in early 2008 when Mancini learned that his compulsive
behaviors may have been caused by taking Mirapex. He presented no evidence or
argument refuting that conclusion. Thus, though his alleged injuries increased when
he persisted in voluntarily taking Mirapex for another two years, those later injuries

                                         -8-
are time-barred. “[T]he infliction of appreciable and actual harm, however uncertain
in amount, will commence the running of the statute of limitations.” 

(quotation omitted). Mancini’s gambling losses in 2006 and 2007 were
“appreciable and actual harm” that triggered accrual of the statute of limitations in
early 2008. See DeRose v. Carswell, 

, 370-77 (Cal. App. 1987),
superseded on other grounds, Quarry v. Doe I, 

, 987 (Cal. 2012).

       C. The Procedural Issue. Mancini argues the district court abused its
discretion by denying his motion to stay defendants’ motion for summary judgment
pending discovery as to whether defendants knew that Mirapex rendered its users
unable to understand the nature or effects of their acts. When a motion for summary
judgment is filed before the completion of discovery, as in this case, Rule 56(d) of the
Federal Rules of Civil Procedure (formerly Rule 56(f)) provides that the district court
may grant such relief if the nonmovant shows “it cannot present facts essential to
justify its opposition.” It is not enough to present a list of facts sought to be
discovered. The nonmovant must “articulate how those facts [a]re relevant to rebut
the movant’s showing of the absence of a genuine issue of fact.” Ray v. American
Airlines, Inc., 

, 923 (8th Cir. 2010) (quotation omitted).

       Here, the district court concluded that “whether Defendants knew that Mirapex
caused such a condition does not shed any light on whether this particular plaintiff,
Mancini, himself, was or was not insane at the time his cause of action accrued.” We
agree. At the time the district court ruled, the case had been pending for over two
years, numerous companion cases had settled, and nothing had prevented Mancini
from conducting discovery or obtaining an expert opinion addressing whether he was
insane within the meaning of § 352(a) when the cause of action accrued in early 2008.
There was no abuse of discretion. See 

(standard of review).

      For the foregoing reasons, the judgment of the district court is affirmed.
                      ______________________________

                                          -9-